Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @siccardi_marco
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @siccardi_marco
-
Marco Siccardi proslijedio/la je Tweet
Our last hour of
@REFINE_H2020 general assembly is taking place. Thank you for all the discussion and special thanks to our advisery board.#nanomedicine#regulation@LippyLiptrott@JodyVoorspoelspic.twitter.com/1Aa2T30FgZ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Marco Siccardi proslijedio/la je Tweet
REFINE
#REFINEDSS Stakeholder Interaction Workshop@REFINE_H2020 AGENDA@prinamea@siccardi_marco@bremesu@KaiMoritzEder@SvenEvenBorgos@ruthbs@Simon89809971@LippyLiptrott@RobVandebriel#nanomedicine#nanotechnology More infos: http://refine-nanomed.com/ pic.twitter.com/hd1LVfYe9I
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We are hiring! Looking for a Research Assistant on PK modelling and
#PBPK? Apply herehttps://www.jobs.ac.uk/job/BWG306/research-assistant-grade-6 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Marco Siccardi proslijedio/la je Tweet
Staff awards nominations are in! Good luck to everyone (especially our ITM staff of course
) https://news.liverpool.ac.uk/2019/10/16/staff-awards-2019-shortlist-announced/ …pic.twitter.com/baR44ryndE
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Marco Siccardi proslijedio/la je Tweet
Today 04/10/19 we launched
@livuniresthemes PhD prog with 11 students supported >22 supervisors in tech4 healthy ageing led by @ProfRachelW @GeriSoc @LivHPartners @NIHRCRN_nwcoast @profbuchan @livuniAgeingpic.twitter.com/r4xpK1JIgJ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Marco Siccardi proslijedio/la je Tweet
Excellent launch of our doctoral training network in Tech4healthyageinghttps://twitter.com/asanakpan/status/1180138852419358720 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Marco Siccardi proslijedio/la je Tweet
Hiring! KTP Associate: Looking for an exciting opportunity that bridges between academic and commercial research, and between Chemistry and Biological disciplines? Well we have an 18 month post that could be perfect.
#postdoc… http://lantsandlaminins.com/2019/09/27/hiring-ktp-associate/ …pic.twitter.com/uJUFzfgAa6
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Fantastic collaboration with
@ryanfdonnelly. Great example of how pharmacokinetic modelling can help the design of novel strategies for drug delivery.@rajolirajith@livuniITMhttps://twitter.com/ryanfdonnelly/status/1175771112556380162 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Marco Siccardi proslijedio/la je Tweet
@REFINE_H2020 reported succesfully about the first project period this week in#Brussels at the#EC. Thanks to the team for the work and thanks to our PO and PTA#nanomedicine#regulation#nanotech#regulatorySciencepic.twitter.com/NN5lNeTeyX
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Marco Siccardi proslijedio/la je Tweet
Recent Publication: Considerations and challenges in developing novel long-acting antiretrovirals modalities for treatment and prevention of HIV-1 infection: a regulatory perspective. http://bit.ly/2kGJFol
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Marco Siccardi proslijedio/la je Tweet
Using thalidomide & efavirenz as case studies,
@ShakirAtoyebi@rajolirajith@siccardi_marco et al describe the utility of PBPK models to assess prenatal drug exposure in this paper. https://www.sciencedirect.com/science/article/pii/S0928098719303392 …pic.twitter.com/B0UhCw2CyA
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
On my way back from the
@UK_QSP_Network meeting. Excellent presentations, great networking and engaging debates!!Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Marco Siccardi proslijedio/la je Tweet
We (me and
@TomHasell) have a PDRA role available that will be working on the project with Unilever to increase the use of recycled plastics in consumer bottles. Can you please promote this to any potentially interested researchers, thanks! https://recruit.liverpool.ac.uk/pls/corehrrecruit/erq_jobspec_version_4.display_form?p_company=1&p_internal_external=E&p_display_in_irish=N&p_process_type=&p_applicant_no=&p_form_profile_detail=&p_display_apply_ind=Y&p_refresh_search=Y&p_recruitment_id=012478 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Marco Siccardi proslijedio/la je TweetHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Marco Siccardi proslijedio/la je Tweet
Our new paper on detection of
#CD8+TCells in the Human vs Mouse#Brain in#Cerebral#malaria has been published! https://doi.org/10.3389/fimmu.2019.01747 …@ttmalawi@mmolyneux999Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Marco Siccardi proslijedio/la je Tweet
“...parents who have decided not to
#vaccinate...are being influenced by#fakenews, social media and anti-vaccination campaigns.” Professor Calum Semple interviewed on@BBCBreakfast today about the UK losing its#Measles free status https://bbc.in/31PmHeB (>2h:21m)pic.twitter.com/4KltwVKIQD
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our new multidisciplinary collaborative project with
@ryanfdonnelly. Exciting science ahead!@rannard_group@livuniITM@BritSocNanoMedhttps://news.liverpool.ac.uk/2019/08/19/novel-nano-engineered-microneedles-to-help-hiv-drug-delivery/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Marco Siccardi proslijedio/la je Tweet
Vacanacy
@livuniphysics Postdoctoral Research Associate in Particle Physics to work on the@ATLASexperiment Closing date 22nd August https://recruit.liverpool.ac.uk/pls/corehrrecruit/erq_jobspec_version_4.display_form?p_company=1&p_internal_external=E&p_display_in_irish=N&p_process_type=&p_applicant_no=&p_form_profile_detail=&p_display_apply_ind=Y&p_refresh_search=Y&p_recruitment_id=012105 …pic.twitter.com/gKOlqOpoxX
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Marco Siccardi proslijedio/la je Tweet
Recent Publication: Long-acting or extended-release antiretroviral products for HIV treatment and prevention in infants, children, adolescents, and pregnant and breastfeeding women: knowledge gaps and research priorities. http://bit.ly/2M99ucP
#ccgheHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Marco Siccardi proslijedio/la je Tweet
Delighted to be hosting the 5th Early Career Researchers’ Annual Meeting of the British Society of Nanomedicine!
@BritSocNanoMed@rannard_group@siccardi_marco@DrMayAzzawi@TomOMcDonald@SIPBS_Strath@UniStrathclyde#nanomedicinepic.twitter.com/nJ7zWWmKF8
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.